Chembio diagnostics, inc. (CEMI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers and grants

36,122

37,930

37,415

35,184

31,634

29,804

31,534

28,297

27,259

24,971

20,268

17,691

16,580

16,947

23,633

26,076

27,827

30,174

25,540

23,768

23,328

23,898

25,599

29,184

30,593

29,778

26,640

23,289

23,996

23,810

24,051

24,302

20,515

20,335

0

0

0

Cash paid to suppliers and employees

44,257

45,655

47,423

48,693

45,614

41,624

36,963

32,981

30,750

30,028

28,514

26,039

24,502

23,677

24,942

25,977

27,785

28,382

26,793

27,223

27,445

27,724

29,067

30,252

29,029

27,506

26,251

23,513

23,327

23,048

22,379

21,163

19,647

18,055

0

0

0

Operating cash flows for operating leases

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amount of cash out flows from finance lease, associated with operating activities.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The amount of interest and tax expenses, net.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest received, net

-

-

-

-

-

-

-

28

11

22

40

42

36

25

10

4

3

2

3

3

5

5

6

6

6

5

6

7

7

7

10

7

6

6

0

0

0

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

2

5

7

9

21

19

16

18

0

0

0

Net cash used in operating activities

-9,952

-9,055

-10,649

-13,790

-14,219

-11,781

-5,388

-4,655

-3,479

-5,034

0

0

0

-

-

-

-

-

-

-

-

-

-

-

1,569

2,277

393

-221

669

761

1,661

3,127

857

2,268

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Patent application costs

296

297

346

72

45

0

0

0

0

-

-

-

-

-

-

-

-

550

450

450

450

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of RVR Diagnostics Sdn Bhd, net of cash acquired

-

-

-

-

-

-

-

-

-

850

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of and deposits on fixed assets

4,003

3,502

3,633

2,294

1,957

1,467

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

885

904

726

0

0

0

Acquisition of and deposits on fixed assets

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-202

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-4,254

-3,753

-9,325

-7,711

-7,494

-6,958

-639

-721

-818

-1,876

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-744

-885

-953

-840

-856

-872

-1,159

-885

-904

-726

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of tax withholding on stock award

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on note payable

219

181

184

156

94

64

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from option exercises

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from option exercises

-

-

-

-

-

71

0

0

0

-

-

-

-

-

-

-

-

0

-0

-0

83

237

237

237

167

31

53

66

95

120

105

93

288

287

0

0

0

Financing cash flows for finance leases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Expenses from sale of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

104

104

87

0

0

0

0

-

-

-

-

Proceeds from credit line

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of credit line

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net

-

-

-

-

-

27,476

10,934

10,934

10,934

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of license obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

875

0

0

0

Payment of loan obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

133

145

158

172

53

0

0

0

-

-

-

-

Payment of capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

21

27

29

24

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

18,301

18,494

35,010

16,385

16,447

27,483

10,990

11,140

11,140

134

0

0

0

-

-

-

-

-

-

-

-

-

-

-

5,663

5,306

5,315

5,317

-168

52

-256

9

203

-667

0

0

0

Effect of exchange rate changes on cash

-226

61

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

DECREASE IN CASH AND CASH EQUIVALENTS

3,867

5,746

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-

-

-

-

-

32

13

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

27,476

10,934

10,934

10,934

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-

6,875

-6,764

-10,299

2,251

2,924

5,177

11,069

-124

-157

762

-2,570

-5,270

-6,271

-5,035

-4,373

-1,810

6,488

6,698

4,755

4,255

-355

-59

245

2,250

157

874

0

0

0

RECONCILIATION OF NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES:
NET LOSS

-15,858

-13,675

-12,956

-11,488

-10,029

-7,865

-6,693

-4,963

-5,408

-6,371

-6,931

-8,484

-14,659

-13,347

-11,438

-9,737

-2,053

-2,397

-2,243

-2,077

-1,559

-1,137

-903

83

-11

530

1,284

275

824

941

6,130

6,898

6,784

6,208

0

0

0

Adjustments:
Depreciation and amortization

2,294

1,916

1,905

1,206

1,035

902

928

950

1,022

1,276

1,274

1,332

1,325

1,139

1,267

1,287

1,318

1,372

1,184

1,061

912

739

698

669

639

607

564

535

534

523

520

490

455

437

0

0

0

Share based compensation

1,271

1,655

1,564

1,132

883

632

387

399

346

384

380

367

386

304

286

285

278

334

378

425

485

447

384

327

263

331

361

360

321

318

294

312

296

189

0

0

0

Change in deferred tax liability

-380

-513

-481

-458

-350

-78

0

0

0

-

-

-

-

5,800

5,233

5,090

-1,105

-1,170

-767

-638

-487

-403

-140

196

161

458

564

67

367

471

-4,890

-4,716

-4,898

-5,155

0

0

0

Provision for doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-34

-6

-6

-101

28

10

10

105

-5

0

0

0

Changes in assets and liabilities:
Accounts receivable

-2,756

-3,764

-2,554

709

3,631

5,150

2,025

2,214

-1,868

-1,298

1,560

92

784

960

-5,306

-4,287

-3,363

-5,915

1,227

3,472

4,918

3,774

2,810

1,529

-1,908

-263

2,932

1,672

1,560

1,850

-80

582

1,995

-952

0

0

0

Inventories

796

1,457

2,080

2,370

3,691

3,077

743

1,355

2,047

1,088

1,808

1,512

371

-242

416

-299

-315

-60

-964

-297

94

449

228

230

1,003

700

709

706

-105

187

449

223

1,114

951

0

0

0

Prepaid expenses and other current assets

-326

-64

-983

-229

203

118

596

-95

-117

-285

213

207

353

136

-21

-89

-52

190

280

156

88

-32

134

221

171

159

-42

-51

-45

20

110

115

173

70

0

0

0

Deposits and other assets

12

90

20

255

129

0

535

521

444

512

-23

-8

-1

-1

-1

-1

-0

0

68

59

7

279

210

222

274

2

0

0

0

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

83

-441

-1,595

-935

1,799

2,599

3,277

2,603

1,231

182

1,082

847

834

211

-1,863

-2,032

-1,973

-2,144

632

945

1,121

636

-115

-133

78

1,005

1,248

1,289

107

514

340

644

1,469

733

0

0

0

Deferred revenue

343

-297

-523

-142

100

372

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Customer deposits and deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

151

-

-150

-195

-495

-340

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in operating activities

-9,952

-9,055

-10,649

-13,790

-14,219

-11,781

-5,388

-4,655

-3,479

-5,034

0

0

0

-

-

-

-

-

-

-

-

-

-

-

1,569

2,277

393

-221

669

761

1,661

3,127

857

2,268

0

0

0

Supplemental disclosures for non-cash investing and financing activities:
Value of deposits on manufacturing equipment transferred to fixed assets in noncash transactions during the period.

-

-

-

-

-

257

232

257

216

174

160

130

1

0

49

43

15

20

559

563

607

603

288

286

329

521

344

468

413

229

181

55

23

0

0

0

0

Amount of right-of-use assets and deferred rent obtained from new operating lease liabilities in noncash transactions during the period.

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The amount of measurement period acquisition adjustment to accounts receivable.

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Refers to accrual of contingent earn out payment during the period.

-

-

-

-

-

-

-

-

-

148

148

148

148

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for net assets of business acquired

-

-

-

-

-

-

-

-

-

1,682

1,682

1,682

1,682

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-